All Activity

Bipartisan senators are weighing in on the Trump administration’s marijuana rescheduling process—including how it could impact the fight to ease banking access for cannabis businesses. Sen. Cory Booker (D-NJ) told Marijuana Moment on Wednesday that it’s “too early to tell” what the implications of President Donald Trump’s executive order directing the Department of Justice to expedite the process of moving cannabis from Schedule I of the Controlled Substances Act (CSA) to Schedule III will be—saying that while there are “things that look promising” about it, he is “very concerned about where the DOJ will land.” “The ability of the Trump administration to speak out of both sides of their mouth is staggering,” he said. “So I’m just going to wait and see right now. Obviously, there’s things that look promising—to end generations of injustice. I really want to wait and see.” DOJ has so far not provided any updates or timelines on the rescheduling process since Trump issued his executive order last month, and Attorney General Pam Bondi—who has historically opposed marijuana reform—was not present at the signing ceremony. Booker added in the interview with Marijuana Moment that the administrative rescheduling move could potentially open to the door to advancing additional cannabis reforms in Congress such as the Secure and Fair Enforcement Regulation Banking Act (SAFER) Banking Act, which would make it easier for marijuana businesses to access financial services. “As a legislator, for me, that might get us an opening to some of the things that are stalled in Congress,” he said. “But ultimately that’s where I feel more comfortable, so that no matter who the president is, we have a structure that works to end the injustices and to liberate, frankly, an industry that has been severely hamstrung.” The senator, who at one point threatened to block the advancement of industry-focused banking legislation if it did not include more equity-focused provisions, said that he’s since “been able to get into SAFER some of the elements that are important to me to be able to support it.” That is likely a reference to the addition of language clarifying that the bill’s safe harbor for banks that work with cannabis businesses is extended to Community Development Financial Institutions (CDFIs) and Minority Depository Institutions (MDIs) that make commercial loans to minority-owned businesses. That said, a current version of the SAFER Banking Act has not yet been reintroduced in either the House or the Senate more than a year after the 119th Congress began. On Thursday, Sen. Bernie Moreno (R-OH), who is expected to be the lead sponsor of the legislation this session, told Marijuana Moment that marijuana banking is “stacked ranked very low” as a priority “because we just have a lot of irons in the fire right now.” Issues that take precedence include “funding the government, getting this healthcare thing done, crypto market structure,” he said. Asked whether the administrative move to reschedule cannabis takes some pressure off of lawmakers to act, he said, “I think so, probably.” Last week, two other GOP senators filed an amendment to block the Trump administration from rescheduling cannabis, but it was not considered on the floor. Meanwhile, earlier this month, the Drug Enforcement Administration (DEA) said a marijuana rescheduling appeal process “remains pending” despite Trump’s executive order. A recent Congressional Research Service (CRS) report discussed how DOJ could, in theory, reject the president’s directive or delay the process by restarting the scientific review into marijuana. The LCB contributed reporting from Washington, D.C. The post Democratic Senator ‘Very Concerned’ About How DOJ Will Handle Marijuana Rescheduling appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Excellent post. I was reviewing this blog continuously, and I am impressed! Extremely helpful information especially this page. Thank you and good luck. olxtoto Took me time to read all the comments, but I really enjoyed the article. It proved to be Very helpful to me and I am sure to all the commenters here! It’s always nice when you can not only be informed, but also entertained! editoto This is a great inspiring article.I am pretty much pleased with your good work.You put really very helpful information. Keep it up. Keep blogging. Looking to reading your next post. sengtoto I am impressed. I don't think Ive met anyone who knows as much about this subject as you do. You are truly well informed and very intelligent. You wrote something that people could understand and made the subject intriguing for everyone. Really, great blog you have got here. olxtoto Very useful post. This is my first time i visit here. I found so many interesting stuff in your blog especially its discussion. Really its great article. Keep it up. olxtoto basket168

This is my first time visit to your blog and I am very interested in the articles that you serve. Provide enough knowledge for me. Thank you for sharing useful and don't forget, keep sharing useful info: situs togel terpercaya I have read your blog it is very helpful for me. I want to say thanks to you. I have bookmark your site for future updates. situs toto Thank you very much for writing such an interesting article on this topic. This has really made me think and I hope to read more. bandar slot online Nice to be visiting your blog again, it has been months for me. Well this article that i've been waited for so long. I need this article to complete my assignment in the college, and it has same topic with your article. Thanks, great share. demo slot pg soft mahjong This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value. Im glad to have found this post as its such an interesting one! I am always on the lookout for quality posts and articles so i suppose im lucky to have found this! I hope you will be adding more in the future... prediksi toto macau situs slot gacor

IN House rejects marijuana amendment; Study: Cannabis classification not aligned with science; Op-Ed: CBD patients need more than fed hemp ban delay Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. Cole Preston of ColeMemo.com: “I support Marijuana Moment because consistent, factual reporting on drug policy is essential—especially as laws change faster than public understanding. Their work helps keep policymakers, advocates and the public grounded in what’s actually happening.” If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW U.S. Department of Agriculture scientists published a study that the agency says “redefined the value of roots in industrial hemp, providing new opportunities for industrial hemp growers and opening new avenues for pediatric cancer research.” The Indiana House of Representatives rejected an amendment that would have allowed farmers to begin cultivating marijuana seed with new special use permits—which the sponsor said would help the state “get prepared” for federal cannabis rescheduling. A new scientific review concludes that “U.S. drug policy does not align with experts’ rankings of drug harms”—finding, for example, that “cannabis was rated as less harmful than its Schedule I status suggests.” Realm of Caring Executive Director Sasha Kalcheff-Korn argues in a new Marijuana Moment op-ed that for hemp farmers and patients who rely on CBD, delaying the federal recriminalization of hemp products is “just a band-aid” and that “regulatory certainty” is needed. The Missouri Division of Cannabis Regulation revised guidance to attempt to clarify whether medical marijuana patients can buy from licensed dispensaries as adult-use consumers—though purchase limit rules complicate the situation. / FEDERAL White House Office of National Drug Control Policy Director Sara Carter Bailey said officials are seeing fentanyl “laced in vapes and marijuana.” Sen. Ted Budd (R-NC) tweeted, “Rescheduling marijuana to a Schedule III substance will put more money in the pockets of marijuana companies & will have detrimental effects on the health and safety of Americans, especially our nation’s youth.” Sen. Susan Collins (R-ME) said in a press release about the Senate Judiciary Committee’s approval of President Donald Trump’s nominee for U.S. attorney for Maine that she’s concerned about “illegal Chinese marijuana grow houses” in her state. / STATES The Maine legislature’s Veterans and Legal Affairs Committee is considering a bill to legalize marijuana consumption lounges. The Ohio legislature’s Ibogaine Treatment Study Committee will meet on Wednesday. A Florida judge issued a split ruling on state officials’ decision to toss signatures for a proposed marijuana legalization ballot initiative. A spokesperson for a Massachusetts campaign seeking to roll back marijuana legalization with a proposed ballot initiative addressed accusations of fraudulent petitioning tactics. The organizer of an Arizona campaign behind a proposed ballot initiative to recriminalize recreational marijuana sales discussed the measure. Michigan regulators published a report on the hemp program. Pennsylvania’s medical cannabis program has seen a decline in patient enrollment over the past year. California regulators are launching a compliance education effort on kratom and 7-OH products ahead of enforcement actions. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Niles Township. Michigan officials are being sued over a local ban on marijuana businesses. The Boston, Massachusetts Cannabis Board will meet on Wednesday. / INTERNATIONAL Victoria, British Columbia, Canada’s police chief said he doesn’t expect to see a spike in drug arrests when the province’s decriminalization trial is concluded at the end of this month. German lawmakers are considering scaling back some proposed restrictive changes to medical cannabis policies. / SCIENCE & HEALTH A study highlighted “the potential of CBD as an adjunctive therapeutic agent for cancer treatment versus non-malignant cells.” A study found that “longer sitting times are associated with a lower likelihood of marijuana use among U.S. adults.” A study found that “acute migraine treatment with 6% THC + 11% CBD was superior to placebo at 2-h post-treatment with sustained benefits at 24 and 48 h.” / ADVOCACY, OPINION & ANALYSIS The New York Post editorial board criticized Gov. Kathy Hochul’s (D) plan to create a Center for Excellence for Cannabis Care and Health Equity. / BUSINESS Colorado retailers sold $108.2 million worth of legal marijuana products in October. / CULTURE A shuttered marijuana business co-owned by Ice-T is facing a lawsuit over allegedly unpaid bills. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Feds tout hemp roots’ potential in kids’ cancer treatment (Newsletter: January 20, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Le code promo 1xBet gratuit: VATOUT. Découvrez comment l'utiliser lors de votre inscription pour obtenir jusqu'à 130 $ de bonus de bienvenue. 1xBet propose des promos sur les paris sportifs et les jeux tout au long de l’année. Chaque mois, des offres récompensent les joueurs actifs, avec des avantages qui varient selon la période et les événements sportifs. nouveau code promo 1xbet

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. togel terpercaya This article gives the light in which we can observe the reality. This is very nice one and gives indepth information. Thanks for this nice article. bandar togel Thank you a bunch for sharing this with all of us you actually realize what you are talking about! Bookmarked. Please also seek advice from my site =). We could have a hyperlink change contract between us! bandar slot Very informative post! There is a lot of information here that can help any business get started with a successful social networking campaign. slot gacor This blog is really great. The information here will surely be of some help to me. Thanks!. syair macau situs slot

est une option fiable pour garder la main sur vos identifiants. code promo 1xbet abidjan

This article highlights the impactful role of women in the cannabis industry through social media. They're building communities and dismantling stigmas. It's inspiring to see this collaboration. It's almost like watching players level up skills strategically, similar to the precision needed in Ragdoll Archers . The legal cannabis world is gaining strength thanks to these dedicated women.

I have read a few of the articles on your website now, and I really like your style of blogging. I added it to my favorites blog site list and will be checking back soon. Please check out my site as well and let me know what you think. apollo tv group

One of the biggest strengths of the Dinosaur Game is its accessibility. It requires no installation, no account, and no learning curve. Anyone with Google Chrome can play it instantly, regardless of age or gaming experience.

What truly makes Geometry Dash unique is its deep connection between gameplay and music. Every jump, fall, and movement is synchronized with energetic electronic tracks.

By removing direct defensive control, Retro Bowl emphasizes strategic decisions and offensive execution rather than overwhelming the player with complex mechanics.

“Merely hitting pause does not protect public health; thoughtful regulation does.” By Sasha Kalcheff-Korn, Realm of Caring While some policymakers are proposing to delay impending hemp restrictions by extending the 2018 Farm Bill, this is just a band-aid and might ultimately create a significant missed opportunity. An extension may temporarily allow farmers to plant this season, but it does nothing to solve the underlying problem. Kicking the can down the road only prolongs uncertainty for farmers, patients and families, plus it guarantees we will be having the same crisis conversation again next year. We create an industry that can’t plan for the future. The right solution is not just delay; it is clarity. Congress has a narrow window right now to fix the language, correct the THC threshold and clearly distinguish intoxicating products from non-intoxicating, therapeutic CBD—and it should take that opportunity while there is momentum and support to do so. Farmers do not need temporary relief; they need regulatory certainty that allows them to operate responsibly and sustainably. And most importantly, the patients and families who rely on this medicine need therapeutical tools they can depend on. Claims that we need “more research” to determine intoxicating levels of THC in CBD products ignore the substantial body of evidence that already exists. Scientific literature, clinical experience and real-world data consistently demonstrate that non-intoxicating CBD products can contain trace amounts of THC well below any level that produces intoxication. This is not theoretical, but it is observable, measurable and already understood. No organization has engaged more deeply or consistently with the community using cannabinoids than Realm of Caring. Through tens of thousands of direct, recorded interactions with patients, caregivers, clinicians and families across the country, we can confidently articulate what constitutes a non-intoxicating level of THC in commercially available CBD products that have been used responsibly for more than a decade. From our perspective, if lawmakers have the opportunity to pass a reasonable, evidence-based solution, particularly with encouragement from a supportive administration, they should take that shot. This challenge can be viewed as a gift for the industry to come together, end the hemp ambiguity and protect workers and patients. But merely hitting pause does not protect public health; thoughtful regulation does. Sasha Kalcheff-Korn is the executive director of Realm of Caring, a Colorado-based nonprofit that advocates for and connects people to cannabinoid therapy. The post Hemp Farmers And Patients Who Rely On CBD Need More Than Just A Delay In The Looming Federal Ban (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“It is largely up to individuals and dispensaries to ensure they are in compliance with the portion of this rule related to purchases.” By Rebecca Rivas, Missouri Independent Missouri cannabis regulators have changed their guidance on whether or not medical marijuana patients can purchase from licensed dispensaries as a regular consumer, following complaints over the last year that the state’s policy was an unconstitutional restriction. But the update ended up causing more confusion about what patients can or can’t do, cannabis advocates say. In the FAQ section of Missouri Department of Health and Senior Services’ website, it lists the question: As a qualifying patient over the age of 21, can I choose to purchase marijuana as a patient and also purchase marijuana as a consumer? Previously, the answer was a straight “no.” “…patient ID card holders are not allowed to purchase as a consumer in a licensed dispensary,” the department, which is Missouri’s cannabis regulatory agency, stated. The rule, regulators said, was meant to ensure that patients and consumers stay within their allowed possession limits. But on December 8, the department changed the answer to say they don’t exactly know. It now says: “State law does not explicitly address the question of whether an individual may choose to purchase marijuana as a consumer once they have been approved as a patient and assigned a purchase and possession limit according to that status.” The Independent asked DHSS if medical patients need to show their patient ID card every time they buy marijuana from a dispensary—a question the cannabis advocacy group Missouri NORML has urged the department to clarify. Lisa Cox, spokeswoman for the department, said the law is “not clear” about it, “so DHSS is not instructing patients that they must do so,” in an email to The Independent. Dan Viets, an attorney and board member for Missouri NORML, said he’s pleased the department has changed its position on that question—but less so on another issue. Viets initially interpreted the department’s update to mean that the state now agreed with NORML that medical patients may purchase the same amount of cannabis as other adult consumers. In general, medical patients are limited to a 6-ounce allotment of dried, unprocessed marijuana every 30 days. Recreational consumers are allowed to purchase up to 3 ounces every day—but they can’t possess more than 3 ounces at any one time. Cox said it is not the department’s position that “patients and consumers have the same purchase limits. These limits are different in law, and patient limits are often specific to each individual.” She said “the law is clear” that individuals may not exceed purchase limitations by combining patient and consumer purchases. For recreational consumers, the state is prohibited by law from tracking their purchases without their permission. However by law, dispensaries are required to track how much medical marijuana patients buy so they don’t exceed their limit. And dispensaries are required to report to the department if they observe an individual exceeding their purchase or possession limits, which can lead to fines or criminal charges, the department’s website states. Cox said penalties for medical patients are uncommon, and the department has never had to revoke a patient card over possession limits. While there are some extra steps involved, Viets said there are good reasons for people to maintain their patient status. “Not only because you pay less sales tax,” Viets said, “but I think more importantly, because you enjoy the constitutional protection against employment discrimination.” Andrew Mullins, executive director of the Missouri Marijuana Trade Association, sent a letter in April to leaders of the Division of Cannabis Regulation claiming the previous FAQ wording was unconstitutional. “We believe that DCR’s interpretation that a Missourian must either be an adult-use consumer or a medical patient is neither good public policy nor a constitutionally sound interpretation,” he wrote. After the FAQ was changed online, MoCann Trade celebrated the revision. “We are thankful that despite some initial confusion, it now appears that DCR agrees that medical marijuana patients can also exercise their purchasing rights as an adult use customer, so long as they abide by the possession limit,” Mullins told The Independent. He said it’s “especially significant” because Missouri has been increasing its patient count, reaching a two-year high in medical marijuana patient applications last month. “This pro-patient policy clarification,” he said, “now complies with the Missouri Constitution and addresses the concerns we previously articulated on behalf of our medical cannabis customers.” Cox said the department is prohibited from tracking consumer purchases, “so it is largely up to individuals and dispensaries to ensure they are in compliance with the portion of this rule related to purchases.” If there is a need to verify an individual’s possession limits, such as with law enforcement, “it is important that patients know the possession limits applicable to them.” The department, she added, will provide as much guidance as it can to patients and consumers on what is allowed so that they remain within their legal possession limits. This story was first published by Missouri Independent. The post Missouri Regulators Move To Clarify Medical Marijuana Patients’ Purchasing Limits appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Indiana House of Representatives defeated an amendment aimed at allowing farmers to begin growing marijuana. The amendment, from Rep. Kyle Miller (D), would have directed the state chemist and seed commissioner to issue special use permits to between three and 10 farmers for the cultivation of marijuana seed, with geographic distribution requirements. While Miller framed the proposal as a way to prepare the state for federal marijuana rescheduling under a recent order from President Donald Trump, it was defeated in a voice vote on Thursday. “While this part of the chapter is open, we should get prepared for what Donald Trump, through his executive order, has asked—to reschedule marijuana from a Schedule I to a Schedule III,” the lawmaker said. “The longer we stick our heads in the sand, we’re hurting our farmers, we’re hurting our constituents. We need to move forward on this issue.” Rep. Mike Aylesworth (R), the sponsor of the bill about state seed law, that Miller was seeking to amend, spoke against the proposed change. “The Indiana criminal code prohibits the possession of marijuana seeds that are capable of germination. This amendment seeks to allow the state seed commissioner to offer permits to farmers for an action that is currently illegal in Indiana,” he said, according to The Times of Northwest Indiana. “The amendment does not alter the criminal code and thus creates a statutory conflict.” A poll released this month shows that nearly three in five Indiana residents back legalizing cannabis for medical and recreational use. It found that 59 percent of residents are in favor of legalizing cannabis for both medical and recreational purposes. An additional 25 percent back only allowing patients to access medical marijuana, raising the total support for that reform to 84 percent. The survey was released just days after Indiana Rep. Mitch Gore (D) filed legislation that would effectively legalize the possession and cultivation of limited amounts of marijuana. It’s one of several reform options on the table so far in the legislature for this year’s session. Cannabis reform advocates have generally struggled to make inroads in the conservative legislature over recent years. That said, the state’s GOP governor said recently that Trump’s move to federally reschedule marijuana could add “a little bit of fire” to the local push for cannabis legalization in his state. Gov. Mike Braun (R) also said last year that he’s “amenable” to medical cannabis legalization. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Braun previously said that “it’s probably time” to allow access to therapeutic cannabis among patients in the state. Those comments came alongside a separate poll indicating that nearly 9 in 10 Indiana adults (87 percent) support marijuana legalization. Top Republicans in the legislature, however, have openly opposed marijuana reform. “It’s no secret that I am not for this,” Senate President Pro Tem Rodric Bray (R) said in late 2024. “I don’t have people coming to me with really compelling medical cases as to why it’s so beneficial. And any state that I’ve seen pass medical marijuana is essentially passing recreational marijuana.” House Speaker Todd Huston (R) doubted any medical benefits associated with marijuana, calling the substance “a deterrent to mental health.” He and others suggested that lawmakers supportive of the reform merely want to boost state revenue. A number of marijuana reform bills were introduced for the Indiana legislature’s 2025 session, including one—from Reps. Jim Lucas (R) and Shane Lindauer (R)—that would have legalized medical marijuana for people with “serious medical conditions as determined by their physician.” The post Indiana House Rejects Amendment To Let Farmers Begin Cultivating Marijuana Seeds appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Marijuana and other drugs are not as dangerous as laws written half a century ago say they are, according to a new scientific review. Since the passage of the Controlled Substances Act (CSA) in 1970, U.S. drug laws have been dictated by rigid categories that supposedly reflect the dangers posed by different substances—but the new study suggests that “drug policy contradicts expert assessments of drug harms” both in America and across the world. The results indicate that governments’ legal rankings for substances bear little resemblance to what experts actually know about which drugs cause the most harm—something that cannabis consumers and much of the general public have long recognized. Marijuana, for example, has been listed as a Schedule I drug in the U.S. for decades. While President Donald Trump signed an executive order directing the attorney general to expeditiously complete the process of moving cannabis to a Schedule III substance last month, that has not yet occurred. In the new paper published in the December 2025 issue of Harm Reduction Journal, a multidisciplinary panel of U.S. researchers, clinicians and people with lived experience of substance use found that federal drug policy is “poorly aligned with scientific evidence” and often contradicts expert assessments of risk. To reach their conclusions, the researchers adapted a method known as multi-criteria decision analysis. Seventeen experts evaluated 19 commonly used drugs across 18 categories of harm, ranging from overdose death and long-term health damage to family disruption, crime and economic cost. Each drug was scored and weighted to produce an overall harm ranking. The study—titled “US drug policy does not align with experts’ rankings of drug harms: a multi-criteria decision analysis”—also found that nearly all drugs were more harmful to the people who use them than to others, a result with significant policy implications. “An array of harm reduction strategies should be considered,” the authors argue, noting that punitive approaches have coincided with rising overdose deaths rather than declines in use. The findings arrive at a moment when federal and state officials are reconsidering long-standing approaches to drug regulation, sentencing and public health response. “For example, cannabis was rated as less harmful than its Schedule I status suggests.” By placing cannabis in the most restrictive legal category—while ranking fentanyl lower in Schedule II and leaving alcohol outside the federal drug scheduling system entirely—U.S. policy has created a framework that the authors say no longer reflects either scientific consensus or actual risk to the population. “Resources should be focused on health and wellness, not on incarceration,” they wrote. Taken together, the study paints a picture of a drug policy frozen in time—one that treats substances like cannabis and psilocybin as major threats while failing to adequately respond to the substances doing the greatest damage. As fentanyl deaths climb and alcohol-related harms persist, the authors suggest that aligning law with evidence is no longer just an academic concern, but a public health imperative. “Psilocybin and cannabis are associated with less harm than many other drugs and with potential medicinal benefits but people who use them remain subject to punishment in many jurisdictions.” The researchers argue that evidence-based scheduling could support a shift away from punitive enforcement and toward targeted harm reduction, expanded treatment access and public health interventions, particularly for fentanyl and alcohol. Noting that “fentanyl was deemed the most harmful drug,” they point to evidence supporting naloxone distribution, fentanyl test strips and supervised consumption sites. Calling for further examination, the authors write that the research “provides a useful starting point for future work in the U.S. that could account for additional drugs, drug benefits, vulnerable subpopulations (e.g., youth), and various methods of use and routes of ingestion.” “Collectively, this work can be used to advance scientific debate about the best ways to reduce harms to people who use drugs and to redress societal impacts at the same time.” The study comes on the heels of the Trump administration backing away from a prior federal recommendation to limit alcohol consumption to specific amounts, even as marijuana remains federally criminalized and more Americans are choosing cannabis for personal health reasons. More changes are also on the horizon. President Trump signed a bill into law last year containing provisions that would remove barriers to conducting research into the risks and benefits of marijuana, psychedelics and other Schedule I drugs. The post Marijuana’s Restrictive Federal Classification Isn’t Supported By Science, New Study Concludes appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Combinés : cumulez plusieurs sélections pour booster vos gains code promo 1xbet casino

You can be permitted to content artists, however it is not connections, in the event they are simply endorsed and additionally relating to question. iptv deutschland

Les autres offres accessibles avec le code promo 1xBet code promo 1xbet yaoundé

The "Wortendo word game" serves as a bridge between traditional word puzzles and modern digital interfaces, preserving the intellectual satisfaction of paper-based puzzles while adding the convenience and features of digital platforms. This hybrid approach respects the history of word games while leveraging technology's advantages, like instant dictionary validation and progress tracking.

The U.S. Department of Agriculture (USDA) is promoting a novel study suggesting that an often underutilized part of the hemp plant—its roots—may hold significant therapeutic potential, including in the treatment of pediatric cancer. Government scientists at USDA’s Agricultural Research Service (ARS) “redefined the value of roots in industrial hemp, providing new opportunities for industrial hemp growers and opening new avenues for pediatric cancer research,” the agency said in a press release this week. The study, published in the Journal of Cannabis Research last year, discovered that there’s a component of hemp roots with four distinct compounds known as “neolignans” that scientists until now have not realized exist in the cannabis crop. “We believe this new discovery offers industrial hemp growers a potential new revenue stream from a part of the plant that was previously overlooked,” Korey Brownstein, a research chemist at the National Center for Agricultural Utilization Research, said. “Unlike crops such as corn or soybeans, which have multiple uses, hemp has been limited in scope,” they said. “But if we treat hemp as a multi-use crop, we can expand its applications and market—paper, grain, fiber, and now, potentially, pharmaceutical compounds from the roots. The discovery of these compounds adds value to this commodity.” While it’s well-known that hemp contains valuable properties as it relates to fibers and grains, as well as extracts like CBD, the roots of the crop “were not considered to hold significant value,” USDA said. After identifying the unique chemical compound in the roots, however, researchers carried out a three-year study to determine whether there could be previously untapped utility in hemp. And working alongside scientists at the University of Illinois College of Medicine, they found the neolignans could have potential for pediatric cancer treatment. Learn more about a groundbreaking study in which ARS scientists are redefining the value of roots in industrial hemp. Their research could provide new opportunities for industrial hemp growers and also open new avenues for pediatric cancer research. https://t.co/kQSlo5NsfU pic.twitter.com/ovbM3E5tzZ — Agricultural Research Service (@USDA_ARS) January 14, 2026 Specifically, the researchers “found that these molecules showed moderate activity in killing pediatric cancer cells (cytotoxic effect) in the laboratory setting.” “Refining and understanding the effect of this molecule on pediatric cancers will open new alternatives for children’s cancers that are unresponsive to current therapies,” USDA said, adding that this “marks the first time these specific neolignans have been isolated from hemp and linked to possessing cytotoxic effects on pediatric cancer cell lines.” Further studies need to be conducted to validate the therapeutic efficacy of the hemp root compound, but Brownstein stressed that this could expand “the possibilities for using the whole industrial hemp plant.” “By adding value to the roots, we’re giving farmers more stability and more reasons to invest in this emerging crop,” he said. The study found that, of the four novel compounds that were tested, one in particular (M4) caused significant inhibition of cell survival in all four cancer cell lines in comparison to the control.” “While our findings demonstrate the cytotoxic effects of hemp-derived compounds on multiple pediatric cancer cell lines, the underlying mechanisms driving these effects remain to be elucidated,” the researchers wrote. “Future studies will focus on detailed mechanistic investigations including cell cycle analysis, apoptosis and necrosis assays, and pathway-level interrogations to uncover the molecular basis of this cytotoxicity.” “Though industrial hemp is more well-known for its cannabinoid content, it contains hundreds of other phytochemicals that may have uses in the functional food and pharmaceutical industry,” the study concluded. “Furthermore, utilizing each part of the hemp plant, including the roots, will reduce agricultural waste and provide additional value to growers.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, another scientific review recently found that CBD “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties. The study follows a series of encouraging discoveries related to the medical properties of cannabidiol. In 2025, for example, a paper published in the journal Pharmacology & Therapeutics, assessed a range of clinical and preclinical findings that the efficacy of chemotherapy drugs can be enhanced by medical marijuana. Also last year, a study found that “patients with cancer using cannabis report significant improvements in cancer-related symptoms.” Photo courtesy of Max Jackson. The post USDA Study Shows Untapped Potential Of Hemp Roots In Pediatric Cancer Treatment appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Break through mental blocks with our "letter boxed hints that actually help". We craft clues that target the puzzle's structural core, such as suggesting which letter cannot be an ending or hinting at a hidden thematic link between words.

Le code promo 1xBet 2026 : 1X200NEW vous permet de bénéficier d'un bonus de bienvenue de 100% jusqu'à 130 €/$ sur les paris sportifs. Une inscription 1xBet ne peut pas être réalisée depuis n’importe quel pays. En effet, le meilleur bookmaker en Afrique n’est disponible que dans certains pays. Voici donc les principaux d’entre eux. comment créer son code promo 1xbet

I found your this post while searching for some related information on blog search...Its a good post..keep posting and update the information. apollo group tv

I think this is an informative post and it is very useful and knowledgeable. therefore, I would like to thank you for the efforts you have made in writing this article. apollo group tv